Cytotoxic & High Potency Compounds Manufacturing

Managing Cell-Based Potency Assays: From Development To Lifecycle Maintenance

Characterization of a biological product — which includes the determination of physicochemical properties, biological activity, immunochemical properties, purity and impurities — is necessary to establish the safety and efficacy profile of a given product (ICH Q6B).  By Dr. Weihong Wang, manager, Molecular and Cell Biology, Eurofins Lancaster Laboratories

Cytotoxic Formulation & Filling DSM expanded their commercial-scale sterile pharmaceutical services by offering filling and lyophilization of cytotoxic products.

Haupt Pharma AG

With nine sites in Germany, Italy, France and Japan, and a representative office in the U.S., Haupt Pharma is one of the largest European companies for pharmaceutical contract development and manufacturing.

Paragon BioServices, Inc.

Founded in 1990, Paragon Bioservices is a CMC Center of Excellence delivering research, development and cGMP manufacturing services to pharmaceutical companies, biotechnology companies and federal agencies

 

Pharma Tech Industries

For more than 35 years, Pharma Tech Industries has built an outstanding reputation as a family-owned business, providing exceptional contract development, contract manufacturing and contract packaging services to the world's leading pharmaceutical, medical devices and consumer products companies.

Roche Custom Biotech

With over 50 years of biotechnology experience, a worldwide presence, and strong customer orientation, Roche Custom Biotech is uniquely positioned to supply the Diagnostics, Pharma, and Biotech industry with products and services, customized to your quality and regulatory needs.

AAIPharma Services Corporation

AAIPharma Services is a top contract drug development, manufacturing and analytical services company providing solutions to pharmaceutical, biotech and healthcare clients.

Sterile Dosage Forms

DSM manufactures sterile dosage form pharmaceuticals, comprising aseptic liquid filling, cytotoxic formulation and filling, and lyophilization.

Active Pharmaceutical Ingredient Development And Manufacture

Active Pharmaceutical Ingredient (API) production is a critical component of drug development. The efficient synthesis of a molecule is a fundamental requirement of success.